美东时间2020年6月05日,ZNTL股价今开48.1300美元,盘中最高50.1500美元,盘中最低43.6100美元,股价收跌5.96%,跌2.8900点,报45.6000美元

ZNTL简介

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It use its highly efficient drug discovery engine, which it refer to as its Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believe could result in potentially differentiated product profiles. Its discovery engine combines its extensive experience and capabilities across cancer biology and medicinal chemistry.